Bakkt Announces Non-Cash Goodwill and Other Intangible Assets Impairment Charge
Bakkt Holdings, Inc. (NYSE: BKKT) completed its annual impairment testing of goodwill and intangible assets, announcing a non-cash impairment charge of approximately $1.3 to $1.4 billion related to goodwill and $150 to $160 million for certain intangible assets as of September 30, 2022. Despite this, the company asserts no impact on future operations, liquidity, or cash flows. The decline was attributed to slower crypto product activations and decreased market capitalization. Bakkt plans to release its Q3 2022 earnings on November 10, 2022, followed by a conference call.
- Management maintains a strong cash position despite the impairment charge.
- The company has a robust partner pipeline and diversified product offerings.
- Significant impairment charge of $1.3 to $1.4 billion on goodwill indicates declining asset value.
- Impairment of $150 to $160 million on intangible assets reflects challenges in market capitalization.
In accordance with generally accepted accounting principles, the Company conducted a quantitative test of goodwill and intangible assets for impairment due to the elongated timing for expected cryptoasset product activations and the decline in its market capitalization as of
“Despite the challenging market dynamics this year that have negatively impacted our stock price and the pace of partner activations, we remain optimistic about our underlying business. The charge is not reflective of our strong cash position, partner pipeline and diversified product offerings, and we remain excited about our future growth potential,” said
As previously announced,
The conference call will be webcast live and archived on the investor relations section of Bakkt’s corporate website under the ‘Events & Presentations’ section, along with any related earnings materials.
About
Bakkt-C
Source:
Note on Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include, but are not limited to, statements regarding Bakkt’s guidance, plans, objectives, expectations and intentions with respect to future operations, products, services and the application of Bakkt’s available cash, among others. Forward-looking statements can be identified by words such as “will,” “likely,” “expect,” “continue,” “anticipate,” “estimate,” “believe,” “intend,” “plan,” “projection,” “outlook,” “grow,” “progress,” “potential” or words of similar meaning. Such forward-looking statements are based upon the current beliefs and expectations of Bakkt’s management and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are difficult to predict and beyond Bakkt’s control. Actual results and the timing of events may differ materially from the results anticipated in such forward-looking statements. You are cautioned not to place undue reliance on such forward-looking statements. Such forward-looking statements relate only to events as of the date on which such statements are made and are based on information available to us as of the date of this press release. Unless otherwise required by law, we undertake no obligation to update any forward-looking statements made in this press release to reflect events or circumstances after the date of this press release or to reflect new information or the occurrence of unanticipated events.
The following factors, among others, could cause actual results and the timing of events to differ materially from the anticipated results or other expectations expressed in such forward-looking statements: (i) the impact of the ongoing COVID-19 pandemic; (ii) changes in the markets in which
View source version on businesswire.com: https://www.businesswire.com/news/home/20221028005456/en/
Investor Relations
Ann.DeVries@bakkt.com
Media
Lauren.Post@bakkt.com
Source:
FAQ
What impairment charge did Bakkt report in Q3 2022?
How does Bakkt's impairment charge affect its future operations?
When will Bakkt release its Q3 2022 earnings report?
What caused the impairment testing for Bakkt?